Krishna Vaddi is Chief Executive Officer of Prelude Therapeutics Inc (PRLD). The company reported total compensation of $1,348,000 for fiscal year 2025.
| Salary | $615,441 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $412,744 |
| Non-equity incentive plan | $309,465 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $10,350 |
| Total | $1,348,000 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Prelude Therapeutics Inc filed April 29, 2026, accession 0001193125-26-191532.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chief Executive Officer | $615,441 | $0 | $0 | $412,744 | $309,465 | $0 | $10,350 | $1,348,000 |
| FY2024 | Chief Executive Officer | $594,167 | $0 | $0 | $1,446,379 | $276,575 | $0 | $10,350 | $2,327,471 |
Totals as disclosed in each year's own compensation disclosure for Prelude Therapeutics Inc.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Krishna Vaddi this page | Chief Executive Officer | $1,348,000 |
| Bryant Lim | Chief Legal Officer, Corporate Secretary, and Chief Financial Officer | $847,397 |
| Peggy Scherle | Chief Scientific Officer | $819,729 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Prelude Therapeutics Inc compensation brief.
Krishna Vaddi's compensation sits inside Prelude Therapeutics Inc's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.